Global Kidney Stone Market 2024–2033

Reports Description

As per the current market research conducted by the CMI Team, the global Kidney Stone Market is expected to record a CAGR of 3.7% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 3,335.5 Million. By 2033, the valuation is anticipated to reach USD 4,625.6 million.

The kidney stone market encompasses the diagnosis, treatment, and management of kidney stone disease, a common urological condition characterized by the formation of crystalline deposits in the urinary tract. It involves a range of medical devices, equipment, and treatment modalities such as lithotripsy, ureteroscopy, and percutaneous nephrolithotomy.

Key players in the market develop innovative solutions to enhance diagnostic accuracy, improve treatment outcomes, and minimize patient discomfort. With the increasing prevalence of kidney stone disease globally, driven by factors like dietary habits and lifestyle changes, the kidney stone market plays a crucial role in addressing the growing burden of this condition.

Kidney Stone Market – Significant Growth Factors

The Kidney Stone Market presents significant growth opportunities due to several factors:

• Increasing Prevalence of Kidney Stone Disease: The rising incidence and prevalence rates of kidney stone disease globally drive the demand for diagnostic and treatment solutions. Factors such as dietary habits, sedentary lifestyles, and metabolic disorders contribute to the growing burden of kidney stone disease, stimulating market growth.

• Technological Advancements in Treatment Modalities: Ongoing advancements in minimally invasive surgical techniques, imaging technologies, and medical devices for kidney stone management enhance treatment outcomes and patient experiences. The adoption of innovative treatment modalities such as shock wave lithotripsy (SWL) and ureteroscopy (URS) drives market expansion by offering effective and less invasive alternatives to traditional surgical approaches.

• Growing Geriatric Population: The aging population is more susceptible to kidney stone formation due to age-related physiological changes and comorbidities. As the global population continues to age, the prevalence of kidney stone disease among older adults rises, driving market demand for diagnostic, treatment, and management solutions tailored to the needs of this demographic group.

• Increasing Awareness and Education: Growing awareness campaigns and educational initiatives about kidney stone prevention, risk factors, and treatment options empower individuals to seek timely medical intervention. Enhanced patient education and awareness efforts contribute to early diagnosis, prompt treatment, and better management of kidney stone disease, fostering market growth.

• Expansion of Emerging Markets: There are opportunities for market expansion in emerging economies with growing healthcare infrastructure and increasing awareness about kidney stone disease. Companies can capitalize on these opportunities by establishing strategic partnerships, expanding distribution networks, and launching targeted marketing campaigns to tap into the potential of these growing markets.

Kidney Stone Market – Mergers and Acquisitions

The Kidney Stone Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Kidney Stone Market include:

• In 2022, Applaud Medical, Inc. (Applaud), a rising player in kidney stone treatment, achieved FDA Breakthrough Device designation for its Acoustic Enhancer technology. This recognition highlights its innovative approach, potentially accelerating regulatory approval and market access, solidifying its position in the kidney stone treatment market.

• In 2022, Dornier MedTech and Endoluxe inked a multi-year exclusive distribution agreement. With both companies specializing in urology market products and systems, this partnership promises innovation and value delivery, bolstering their presence and offerings in the urology segment.

These mergers and acquisitions have helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Kidney Stone Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.

COMPARATIVE ANALYSIS OF THE RELATED MARKET

Kidney Stone Market – Significant Threats

The Kidney Stone Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:

• Regulatory Challenges and Compliance Issues: Stringent regulatory requirements and compliance standards governing medical devices and treatments for kidney stone management pose significant challenges to market players. Non-compliance with regulatory guidelines, including those related to product safety, efficacy, and quality assurance, may lead to delays in product approvals, recalls, or even fines, negatively impacting market growth and reputation.

• Increasing Competition and Price Pressure: The kidney stone market is characterized by intense competition among key players, leading to price pressure and margin erosion. Entry of new competitors, particularly generic manufacturers, and pricing strategies aimed at gaining market share can erode profitability for existing market players, posing a threat to their market position and sustainability.

• Rising Healthcare Costs and Reimbursement Challenges: Escalating healthcare costs and reimbursement challenges pose significant threats to market growth in the kidney stone market. Reimbursement policies, coverage limitations, and payer restrictions on certain treatments and procedures may impact patient access to kidney stone management solutions, affecting market demand and revenue streams for healthcare providers and medical device manufacturers.

• Adverse Events and Product Liabilities: Adverse events associated with kidney stone treatments and medical devices, such as device malfunctions, complications, or patient injuries, pose significant risks to market players. Product liabilities, litigation costs, and reputational damage resulting from adverse events can have serious consequences for manufacturers, leading to legal and financial liabilities, as well as loss of consumer trust and market share.

Category-Wise Insights:

By Type of Treatment

• Extracorporeal Shock Wave Lithotripsy (ESWL): ESWL uses shock waves to break kidney stones into smaller pieces, allowing them to pass out of the body through urine. Trends include advancements in lithotripter technology, such as improved targeting and reduced treatment times, enhancing patient comfort and treatment outcomes.

• Ureteroscopy (URS): URS involves the insertion of a thin, flexible scope through the urethra and bladder to reach and remove kidney stones. Trends include the development of smaller, more maneuverable scopes and accessories, enabling precise stone targeting and minimally invasive procedures with reduced patient discomfort.

• Percutaneous Nephrolithotomy (PCNL): PCNL is a minimally invasive surgical procedure involving the insertion of a nephroscope through a small incision in the back to remove kidney stones. Trends include advancements in imaging technologies and surgical instruments, enabling more precise stone localization and improved surgical outcomes with reduced complications.

• Others: Other treatment options for kidney stones may include medications, dietary modifications, and lifestyle changes aimed at preventing stone formation and recurrence. Trends in this segment include the development of novel pharmacological agents and dietary supplements for kidney stone prevention and management, catering to patient preferences and needs.

Type of Kidney Stone

• Calcium Stones: Calcium stones are the most common type of kidney stone, primarily composed of calcium oxalate or calcium phosphate. Trends include the increasing prevalence due to dietary factors and metabolic disorders, driving demand for diagnostic tools and treatment modalities tailored to calcium stone management.

• Struvite Stones: Struvite stones, also known as infection stones, are composed of magnesium ammonium phosphate. Trends include the focus on infection control measures and minimally invasive treatment options such as ureteroscopy and percutaneous nephrolithotomy (PCNL).

• Uric Acid Stones: Uric acid stones form due to high levels of uric acid in the urine. Trends include the rising incidence associated with dietary habits and metabolic conditions like gout, driving demand for medications to lower uric acid levels and surgical interventions such as shock wave lithotripsy (SWL).

• Cystine Stones: Cystine stones result from a genetic disorder causing excessive cystine in the urine. Trends include advancements in genetic testing for early diagnosis and the development of targeted therapies to prevent cystine stone formation.

• Others: Other types of kidney stones include mixed stones, infectious stones, and rare types like xanthine stones. Trends in this segment include efforts to improve diagnostic accuracy through advanced imaging technologies and personalized treatment approaches based on stone composition analysis.

By End User

• Hospitals and Clinics: Hospitals and clinics are primary healthcare facilities providing comprehensive kidney stone diagnosis and treatment services. Trends include the increasing adoption of minimally invasive surgical techniques like ureteroscopy and percutaneous nephrolithotomy (PCNL) for kidney stone management, as well as the integration of advanced imaging technologies for accurate diagnosis and treatment planning.

• Ambulatory Surgical Centers (ASCs): ASCs specialize in providing same-day surgical procedures, including kidney stone treatments. Trends include the rising popularity of minimally invasive procedures like shock wave lithotripsy (SWL) and ureteroscopy (URS) in ASC settings, offering convenience and shorter recovery times for patients, as well as advancements in surgical equipment and techniques to enhance procedural efficiency.

• Specialty Clinics: Specialty clinics focus exclusively on urological conditions, including kidney stone disease, offering specialized diagnostic and treatment services. Trends include the incorporation of comprehensive metabolic evaluations and dietary counselling into kidney stone management protocols, as well as the use of advanced imaging modalities like CT scans and ultrasound for precise stone localization and characterization.

• Others: This category encompasses alternative healthcare settings, such as academic medical centers, research institutes, and telemedicine platforms, offering kidney stone-related services. Trends include the integration of telemedicine consultations for remote patient evaluation and follow-up, as well as the development of mobile applications and digital health solutions for self-management and monitoring of kidney stone disease.

Report Scope

Kidney Stone Market – Regional Analysis

The Kidney Stone Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:

• North America: In North America, a trend observed is the increasing adoption of advanced minimally invasive surgical techniques for kidney stone management, including ureteroscopy and percutaneous nephrolithotomy (PCNL). Additionally, there’s a growing emphasis on preventive strategies and metabolic evaluations to address the underlying causes of kidney stone formation, reflecting a shift towards comprehensive patient-centered care approaches.

• Europe: Europe showcases a trend towards the integration of multidisciplinary kidney stone clinics, bringing together urologists, nephrologists, and dieticians to provide holistic care. Moreover, there’s a focus on standardizing treatment protocols and improving access to advanced imaging technologies, such as computed tomography (CT) scans and magnetic resonance imaging (MRI), to enhance diagnostic accuracy and treatment planning.

• Asia-Pacific: In the Asia-Pacific region, a notable trend is the increasing adoption of shock wave lithotripsy (SWL) as a primary treatment modality for kidney stones, driven by its cost-effectiveness and accessibility in resource-limited settings. Additionally, there’s growing interest in traditional herbal remedies and alternative therapies for kidney stone prevention and management, reflecting cultural preferences and indigenous healthcare practices.

• LAMEA (Latin America, Middle East, and Africa): The LAMEA region exhibits a trend towards the expansion of kidney stone treatment infrastructure, with a focus on improving access to specialized urological care in urban and rural areas. Furthermore, there’s an increasing emphasis on public health initiatives and awareness campaigns to promote kidney stone prevention strategies, including hydration, dietary modifications, and lifestyle interventions, to address the rising burden of kidney stone disease.

Competitive Landscape – Kidney Stone Market

The Kidney Stone Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:

• Boston Scientific Corporation
• Olympus Corporation
• Cook Medical Inc.
• DirexGroup
• R. Bard Inc.
• Dornier MedTech GmbH
• Siemens Healthineers AG
• Stryker Corporation
• Richard Wolf GmbH
• Karl Storz SE & Co. KG
• Allengers Medical Systems Limited
• EMS Electro Medical Systems S.A.
• Medispec Ltd.
• Convergent Laser Technologies
• Elmed Electronics & Medical Industry & Trade Inc.
• Others

These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.

New players entering the kidney stone market with innovative solutions include Medi-Tate Ltd., introducing the groundbreaking iTind treatment for ureteral stones, and SonoMotion, developing novel ultrasonic propulsion devices for stone expulsion.

Dominant key players such as Boston Scientific Corporation, Olympus Corporation, and Cook Medical Inc. maintain market leadership through extensive R&D investments, diversified product portfolios, and strategic acquisitions.

These key players leverage their established brand reputation, global distribution networks, and strong relationships with healthcare providers to capture significant market share and drive innovation in kidney stone management.

The Kidney Stone Market is segmented as follows:

Type of Treatment

• Extracorporeal Shock Wave Lithotripsy (ESWL)
• Ureteroscopy (URS)
• Percutaneous Nephrolithotomy (PCNL)
• Others

By Type of Kidney Stone

• Calcium Stones
• Struvite Stones
• Uric Acid Stones
• Cystine Stones
• Others

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America